Media Contact

    • 01 January 2018
    • Grigorian Quoted in Law360 about Hot Practice Areas for 2018

    • Partner Chris Grigorian was quoted in a Law360 article, “The 4 Hottest Practice Areas for 2018,” about how the autonomous vehicle industry is continuing to pose new public policy questions and legal issues for corporations in the automotive space.
    • 05 December 2017
    • Rosen Comments on Proposed New FDA Guidance on Drug-Device Combination Products

    • Partner David Rosen is quoted in a Health Care on Bloomberg Law article, “FDA Seeks to Speed Approvals of Generic Drug-Device Combos,” about proposed new FDA guidance that will make it easier for generic companies to get drug-device combination products approved.
    • 08 December 2017
    • Swift Comments on Proposed Changes in ‘Unmasking’ Policy

    • Partner Christopher Swift is quoted in a U.S. News & World Report article, “Exclusive: U.S. Spy Chief Orders Changes in ‘Unmasking’ Policy,” about a proposal by Director of National Intelligence Dan Coats to impose tighter restrictions on how the names of Americans kept secret in intelligence reports can be revealed during presidential transitions.
    • 29 December 2017
    • Beaver Addresses FDA’s Planned New Guidance for Drug Developers

    • Partner Nathan Beaver was quoted in a BNA Health Care Blog article, ”FDA to Provide Earlier, Better Advice to Drug Developers,” about the FDA’s efforts to enhance its communications with drug suppliers as a way of lowering the cost of drug development.
    • 26 November 2017
    • Swift Discusses Flynn’s Potential Legal Problems

    • Partner Christopher Swift was interviewed on Fox News about former White House national security advisor Michael Flynn’s potential legal exposure stemming from his failure to timely register his consulting firm under an obscure federal statute known as the Foreign Agents Registration Act, which requires anybody receiving money from and advocating on behalf of a foreign government to register periodically with the Department of Justice.
    • 28 November 2017
    • Rosen Comments on FDA Commissioner’s Remarks

    • Partner David Rosen is quoted in a Pink Sheet article, “Gottlieb’s Complex Generics Remarks Could Signal (Some) Increased Flexibility,” about FDA Commissioner Scott Gottlieb’s remarks on generic copies of products with drug and device constituent parts at an internal FDA event for agency scientists and researchers.
    • 01 January 2018
    • Walsh Quoted in Law360 about Health Care Policy in 2018

    • Jennifer Walsh, a public affairs director, was quoted in a Law360 article, “Health Care Policy to Watch in 2018,” about the political implications of health care reform and other health care policies in the new year.
    Filters applied:
    Search phrase entered: